Response to the letter from Warren et al.

Hiroki Takanari, Magda S C Fontes, Marcel A G van der Heyden, Marc A Vos, Toon A B van Veen

Journal: Cardiovascular research 2019;113(14):1799-1800

PMID: 29036544

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Address: Clinical Research Center for Diabetes, Tokushima University Hospital, 2-50-1 Kuramoto-cho, Tokushima 770-8503, Japan.; Laboratory of Experimental Cardiology, Department of Cardiology, Heart Lung Center Leiden, Albinusdreef 2, 2300RC Leiden, The Netherlands and Division of Heart & Lungs, Department of Medical Physiology, University Medical Center Utrecht, Yalelaan 50, 3584CM Utrecht, The Netherlands.; Division of Heart & Lungs, Department of Medical Physiology, University Medical Center Utrecht, Yalelaan 50, 3584CM Utrecht, The Netherlands.

DOI: 10.1093/cvr/cvx200

Link outs

Free resources

Other Literature Sources:

https://scite.ai/reports/29036544

Subscription / membership required

Full Text Sources:

MeSH Terms: Anti-Arrhythmia Agents, Calcium-Calmodulin-Dependent Protein Kinase Type 2, Calmodulin, Cell Communication, Heart